Headache & Pain

Filter Your Results

 

News

 

Phase 3 Trial of Dioscorea japonica Extracts To Be Initiated for Treatment of Pain From Diabetic Neuropathy

Tuesday, January 08, 2019—The planned initiation of a phase 3 double-blind, placebo controlled, 12-week study of Dioscorea japonica extracts (NB-01; Neurobo, Boston, MA) for pain relief in pa…

2018 Drug and Device Approvals for Neurology

January 2019—HEADACHE & PAIN Noninvasive Vagus Nerve Stimulation (Gammacore; electroCore, Basking Ridge, NJ) Cleared: November 28, 2018 and January 29, 2018 Indications: adjun…

Hometown Highlights: CGRP-Related Treatments for Headache

With Stephen D. Silberstein, MD

January 2019— What Is Most Significant About These New Treatments? For the first time, we’ve developed a treatment for migraine based on what causes migraine. We had the concep…

Cognitive Complaints and Neuropsychologic Testing

Nabil Ali, MD; Kendra Corning, PsyD, HSPP; and Laura M. Clark, PhD, ABPP

January 2019—When should neuropsychologic tests be ordered and what questions should testing answer?

American Academy of Neurology Call for Uniformity in Brain Death Standards

Thursday, January 03, 2019—Noting that only 1 state, Nevada, has adopted legislation requiring use of medically accepted guidelines for determining brain death, the American Academy of Neurology (AAN) i…

New Drug Application Accepted for Combined Bupivacaine/Meloxicam for Post-Operative Pain

Wednesday, January 02, 2019—The Food and Drug Administration (FDA) has accepted a new drug application (NDA) for fixed-dose combined bupivacaine/meloxicam (HTX-011; Heron Therapeutics, San Diego, CA), an…

Long-Term Safety and Tolerability of Rimegepant for Treatment of Migraine

Thursday, December 13, 2018—Initial results from an ongoing, open-label safety study of the oral calcitonin gene-related peptide (CGRP) receptor antagonist, rimegepant, show that the drug may be effectiv…

Positive Results in Phase 3 Trial of Rimegepant for Oral Acute Treatment of Migraine

Wednesday, December 05, 2018—Results from a phase 3 clinical trial show that treatment with rimegepant (Zydis; Biohaven, New Haven, CT) provided significantly more relief from pain and most bothersome sym…

 
 

Contact Info

For advertising rates and opportunities:
Wendy Terry
Publisher
217-652-3859
wterry@bmctoday.com

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.

 
  • BRYN MAWR COMMUNICATIONS III, LLC